Evidence map›Paper›PMID 41234333›Full record

ReviewSeminars in interventional radiology2025

REBOA is Here to Stay: How to Manage the Resulting Complications.

Sarah Lauve, Sabrina Yu Alfonzo, Kevin Choi, Ross Dies, Danielle Sethi, Lizzie Williams, Claudie Sheahan, Malachi Sheahan

Abstract readReview
In one paragraph

Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah LauveDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Sabrina Yu AlfonzoDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Kevin ChoiDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Ross DiesDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Danielle SethiDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Lizzie WilliamsDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Claudie SheahanDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.
Malachi SheahanDivision of Vascular and Endovascular Surgery, LSU Health Sciences Center, School of Medicine, New Orleans, Louisiana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a critical adjunct in the management of trauma-related shock, serving as a temporizing measure to preserve vital organ perfusion and allow time to achieve definitive hemorrhagic control. However, the increasing adoption of REBOA into clinical practice is associated with a spectrum of potential complications that significantly increase morbidity and mortality in the setting of acute traumatic injury. There is little existing research to guide clinical decision-making and monitoring for these feared complications, especially iatrogenic vascular injuries. This paper synthesizes the current evidence on the classification, frequency, and management of vascular complications following REBOA insertion in the setting of trauma in addition to our observations and experiences as a level I trauma center.

Indexed as

complicationinterventional radiologyREBOAtraumavascular surgery

Identifiers

PMID41234333
PMCPMC12606059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.